Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Free Cash Flow across 17 years of filings, most recently posting $387025.0 for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $387025.0, down 89.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 74.38% YoY), and the FY2025 annual result was $4.8 million, up 812.39% from the prior year.
• Free Cash Flow came in at $387025.0 for Q1 2026 at Cumberland Pharmaceuticals, up from $3025.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $5.2 million in Q2 2023 to a low of -$2.2 million in Q1 2024.
• The 5-year median for Free Cash Flow is $817315.0 (2025), against an average of $1.1 million.
• Across the five-year window, Free Cash Flow tumbled 759.5% in 2023 and soared 276.79% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Free Cash Flow stood at $3.8 million in 2022, then sank by 73.85% to $991448.0 in 2023, then jumped by 91.87% to $1.9 million in 2024, then tumbled by 99.84% to $3025.0 in 2025, then jumped by 12694.21% to $387025.0 in 2026.
• The last three Free Cash Flow figures came in at $387025.0 (Q1 2026), $3025.0 (Q4 2025), and $163392.0 (Q3 2025), per Business Quant data.